REVERGIS Trademark

Trademark Overview

On Monday, July 2, 2001, a trademark application was filed for REVERGIS with the United States Patent and Trademark Office. The USPTO has given the REVERGIS trademark a serial number of 76279922. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Tuesday, May 27, 2003. This trademark is owned by Human Genome Sciences, Inc.. The REVERGIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in promoting the growth and repair of epithelial cells; pharmaceutical preparations for use in the treatment of alimentary tract disorders, allergic conditions, autoimmune diseases, blood disorders, bone diseases and injuries, bone marrow and stem cell transplantation, cardiovascular diseases, central nervous system disorders, connective tissue disorders, critical care, ear, nose and throat conditions, endocrinology disorders, gastrointestinal diseases, genetic disease, immunologic conditions, infectious diseases, joint diseases, kidney diseases, liver diseases, metabolic diseases, neurologic disorders, nutritional disorders, obstetric, gynecological and reproductive disorders, oncologic conditions, ophthalmologic diseases, organ transplantation, pancreatic disorders, poisoning, psychiatric disorders, respiratory diseases, dermatologic disorders, substance abuse disorders, thrombotic diseases, vascular diseases, tendon and muscular injuries, back inj...
revergis

General Information

Serial Number76279922
Word MarkREVERGIS
Filing DateMonday, July 2, 2001
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateTuesday, May 27, 2003
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 3, 2002

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in promoting the growth and repair of epithelial cells; pharmaceutical preparations for use in the treatment of alimentary tract disorders, allergic conditions, autoimmune diseases, blood disorders, bone diseases and injuries, bone marrow and stem cell transplantation, cardiovascular diseases, central nervous system disorders, connective tissue disorders, critical care, ear, nose and throat conditions, endocrinology disorders, gastrointestinal diseases, genetic disease, immunologic conditions, infectious diseases, joint diseases, kidney diseases, liver diseases, metabolic diseases, neurologic disorders, nutritional disorders, obstetric, gynecological and reproductive disorders, oncologic conditions, ophthalmologic diseases, organ transplantation, pancreatic disorders, poisoning, psychiatric disorders, respiratory diseases, dermatologic disorders, substance abuse disorders, thrombotic diseases, vascular diseases, tendon and muscular injuries, back injuries and joint injuries, skin wounds and soft tissue wounds

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 13, 2001
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHuman Genome Sciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameHuman Genome Sciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Monday, August 18, 2003ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 26, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 3, 2002PUBLISHED FOR OPPOSITION
Wednesday, August 14, 2002NOTICE OF PUBLICATION
Thursday, June 6, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 1, 2002EXAMINERS AMENDMENT MAILED
Wednesday, February 20, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 29, 2001NON-FINAL ACTION MAILED
Friday, August 24, 2001ASSIGNED TO EXAMINER

Related Keywords

revergis diseases disorders conditions transplantation pharmaceutical bone injuries preparations nutritional obstetric